Clinical Trial Update: The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the impact of Botox (onabotulinumtoxinA) on neuroimmune interactions in atopic dermatitis; the study is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Daniel Kaplan | Conditions: Atopic Dermatitis (AD) | Phase 1 | Status: RECRUITING